Overview

Assessment of Compliance With Antihypertensive Telmisartan Therapy

Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to asses the efficacy and safety of Telmisartan depending on the use of an electronic therapy monitoring device (HelpingHand) in a real life setting and to asses patients compliance to the therapy with Telmisartan in relation to use of electronic therapy monitoring device.
Details
Lead Sponsor:
Bayer
Collaborator:
Bang & Olufsen Medicom
Treatments:
Antihypertensive Agents
Telmisartan